GL
PFE icon

Graypoint LLC’s Pfizer PFE Stock Holding History

Graypoint LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.08M Buy
44,467
+2,573
+6% +$60K 0.06% 200
2025
Q1 		$1.06M Buy
41,894
+1,366
+3% +$35.7K 0.07% 194
2024
Q4 		$1.08M Buy
40,528
+3,911
+11% +$106K 0.07% 188
2024
Q3 		$1.06M Buy
36,617
+3,852
+12% +$112K 0.07% 183
2024
Q2 		$917K Buy
32,765
+566
+2% +$15.6K 0.06% 189
2024
Q1 		$894K Sell
32,199
-1,361
-4% -$37.8K 0.06% 189
2023
Q4 		$966K Sell
33,560
-15,765
-32% -$477K 0.08% 168
2023
Q3 		$1.64M Sell
49,325
-1,090
-2% -$38.5K 0.15% 116
2023
Q2 		$1.85M Sell
50,415
-3,390
-6% -$132K 0.18% 94
2023
Q1 		$2.2M Sell
53,805
-7,574
-12% -$327K 0.24% 82
2022
Q4 		$3.15M Sell
61,379
-3,482
-5% -$167K 0.38% 68
2022
Q3 		$2.84M Buy
64,861
+5,026
+8% +$244K 0.37% 70
2022
Q2 		$3.14M Sell
59,835
-1,626
-3% -$82.9K 0.4% 65
2022
Q1 		$3.18M Buy
61,461
+7,832
+15% +$406K 0.31% 70
2021
Q4 		$3.17M Buy
53,629
+3,680
+7% +$182K 0.33% 71
2021
Q3 		$2.15M Buy
49,949
+1,348
+3% +$59.7K 0.26% 76
2021
Q2 		$1.9M Sell
48,601
-875
-2% -$34K 0.25% 74
2021
Q1 		$1.79M Sell
49,476
-5,347
-10% -$190K 0.27% 77
2020
Q4 		$2.02M Sell
54,823
-8,416
-13% -$309K 0.35% 65
2020
Q3 		$2.2M Sell
63,239
-6,594
-9% -$231K 0.43% 63
2020
Q2 		$2.17M Buy
69,833
+1,520
+2% +$51.6K 0.49% 57
2020
Q1 		$2.12M Buy
+68,313
New +$2.33M 0.59% 50

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Graypoint LLC's PFE Position: Q2 2025 in Review

Graypoint LLC increased its Pfizer (PFE) stake by 6.1% in Q2 2025, buying an estimated $60K and bringing the position to 44,467 shares worth $1.08M. The position accounts for 0.06% of the portfolio, ranked #200.

Graypoint LLC first reported a position in PFE in Q1 2020 and has held it in 22 quarters since. The position peaked at $3.18M in Q1 2022. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Graypoint LLC held 44,467 shares of Pfizer worth $1.08M as of Q2 2025.
  • Graypoint LLC bought 2,573 Pfizer shares in Q2 2025, an estimated $60K.
  • Pfizer made up 0.06% of Graypoint LLC's portfolio in Q2 2025, its #200 holding.
  • Graypoint LLC first reported a position in Pfizer in Q1 2020 and has held it in 22 quarters since.
  • Graypoint LLC's Pfizer position peaked at $3.18M in Q1 2022.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.